Found 6 hits for monomerid = 50355391 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50355391
(CHEMBL1834659)Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl Show InChI InChI=1S/C26H30Cl2N6O4/c1-33(26(35)32-25-23(27)19(36-2)14-20(37-3)24(25)28)22-15-21(29-16-30-22)31-17-6-8-18(9-7-17)38-13-12-34-10-4-5-11-34/h6-9,14-16H,4-5,10-13H2,1-3H3,(H,32,35)(H,29,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of CYP3A4 using DBF as substrate |
J Med Chem 54: 7066-83 (2011)
Article DOI: 10.1021/jm2006222 BindingDB Entry DOI: 10.7270/Q22N52N1 |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50355391
(CHEMBL1834659)Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl Show InChI InChI=1S/C26H30Cl2N6O4/c1-33(26(35)32-25-23(27)19(36-2)14-20(37-3)24(25)28)22-15-21(29-16-30-22)31-17-6-8-18(9-7-17)38-13-12-34-10-4-5-11-34/h6-9,14-16H,4-5,10-13H2,1-3H3,(H,32,35)(H,29,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of CYP3A4 using BFC as substrate |
J Med Chem 54: 7066-83 (2011)
Article DOI: 10.1021/jm2006222 BindingDB Entry DOI: 10.7270/Q22N52N1 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50355391
(CHEMBL1834659)Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl Show InChI InChI=1S/C26H30Cl2N6O4/c1-33(26(35)32-25-23(27)19(36-2)14-20(37-3)24(25)28)22-15-21(29-16-30-22)31-17-6-8-18(9-7-17)38-13-12-34-10-4-5-11-34/h6-9,14-16H,4-5,10-13H2,1-3H3,(H,32,35)(H,29,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of CYP2C9 using MFC as substrate |
J Med Chem 54: 7066-83 (2011)
Article DOI: 10.1021/jm2006222 BindingDB Entry DOI: 10.7270/Q22N52N1 |
More data for this Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50355391
(CHEMBL1834659)Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl Show InChI InChI=1S/C26H30Cl2N6O4/c1-33(26(35)32-25-23(27)19(36-2)14-20(37-3)24(25)28)22-15-21(29-16-30-22)31-17-6-8-18(9-7-17)38-13-12-34-10-4-5-11-34/h6-9,14-16H,4-5,10-13H2,1-3H3,(H,32,35)(H,29,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of CYP1A2 using CEC as substrate |
J Med Chem 54: 7066-83 (2011)
Article DOI: 10.1021/jm2006222 BindingDB Entry DOI: 10.7270/Q22N52N1 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50355391
(CHEMBL1834659)Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl Show InChI InChI=1S/C26H30Cl2N6O4/c1-33(26(35)32-25-23(27)19(36-2)14-20(37-3)24(25)28)22-15-21(29-16-30-22)31-17-6-8-18(9-7-17)38-13-12-34-10-4-5-11-34/h6-9,14-16H,4-5,10-13H2,1-3H3,(H,32,35)(H,29,30,31) | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of CYP2D6 using AMMC as substrate |
J Med Chem 54: 7066-83 (2011)
Article DOI: 10.1021/jm2006222 BindingDB Entry DOI: 10.7270/Q22N52N1 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50355391
(CHEMBL1834659)Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(OCCN4CCCC4)cc3)ncn2)c1Cl Show InChI InChI=1S/C26H30Cl2N6O4/c1-33(26(35)32-25-23(27)19(36-2)14-20(37-3)24(25)28)22-15-21(29-16-30-22)31-17-6-8-18(9-7-17)38-13-12-34-10-4-5-11-34/h6-9,14-16H,4-5,10-13H2,1-3H3,(H,32,35)(H,29,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of CYP2C19 using CEC as substrate |
J Med Chem 54: 7066-83 (2011)
Article DOI: 10.1021/jm2006222 BindingDB Entry DOI: 10.7270/Q22N52N1 |
More data for this Ligand-Target Pair | |